|
GPSM2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.235100E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.500300E-02 |
| Normal-vs-Stage2 |
8.409900E-02 |
| Normal-vs-Stage3 |
3.621200E-01 |
| Normal-vs-Stage4 |
5.218000E-03 |
| Stage1-vs-Stage2 |
2.711000E-01 |
| Stage1-vs-Stage3 |
1.673820E-01 |
| Stage1-vs-Stage4 |
2.236800E-01 |
| Stage2-vs-Stage3 |
1.384420E-01 |
| Stage2-vs-Stage4 |
5.585200E-01 |
| Stage3-vs-Stage4 |
2.782200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.715390E-03 |
| Normal-vs-AfricanAmerican |
6.232600E-01 |
| Normal-vs-Asian |
9.362400E-02 |
| Caucasian-vs-AfricanAmerican |
3.939000E-03 |
| Caucasian-vs-Asian |
8.611800E-01 |
| AfricanAmerican-vs-Asian |
1.364370E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.084980E-03 |
| Normal-vs-Female |
3.642400E-01 |
| Male-vs-Female |
5.621200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.643020E-01 |
| Normal-vs-Age(41-60Yrs) |
1.042360E-02 |
| Normal-vs-Age(61-80Yrs) |
2.774300E-02 |
| Normal-vs-Age(81-100Yrs) |
6.154000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.553200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.931400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.289200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.299400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.277500E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.855400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.812500E-02 |
| Normal-vs-Grade 2 |
1.279980E-01 |
| Normal-vs-Grade 3 |
3.023800E-02 |
| Normal-vs-Grade 4 |
6.524900E-03 |
| Grade 1-vs-Grade 2 |
1.715580E-03 |
| Grade 1-vs-Grade 3 |
1.775460E-04 |
| Grade 1-vs-Grade 4 |
1.775860E-04 |
| Grade 2-vs-Grade 3 |
5.962600E-01 |
| Grade 2-vs-Grade 4 |
8.233800E-02 |
| Grade 3-vs-Grade 4 |
1.665440E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.945200E-01 |
| Normal-vs-ccB subtype |
1.026350E-04 |
| ccA subtype-vs-ccB subtype |
6.03590000000098E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.421700E-03 |
| Normal-vs-N1 |
5.981200E-03 |
| N0-vs-N1 |
4.018000E-01 |
|
|
